Skip to main content

Table 2 Comparison of characteristics and in-hospital complications between those with and without CHD

From: Impact of congenital heart disease on outcomes among pediatric patients hospitalized for influenza infection

Variables

Presence of CHD

Yes

No

Total influenza cases

2174

123,296

Age, years (median, IQR)

3 (2–7)

5 (2–11)*

Female

977 (44.9%)

56,078 (45.8%)

Race

 

 White

858 (45.0%)

48,547 (47.8%)

 Black

298 (15.6%)

20,522 (20.2%)

 Hispanic

575 (30.2%)

22,796 (22.4%)

 Others

174 (9.1%)

9733 (9.6%)

Discharge quarter

 Jan-Mar

678 (31.3%)

36,224 (29.4%)

 Apr-Jun

398 (18.3%)

15,321 (12.4%)

 Jul-Sep

193 (8.9%)

10,038 (8.2%)

 Oct-Dec

900 (41.5%)

61,642 (50.0%)

Comorbid conditions

 Asthma

521 (24.0%)

34,410 (27.9%)*

 Congenital respiratory anomalies

112 (5.1%)

704 (0.6%)*

 Congenital musculoskeletal anomalies

98 (4.5%)

1228 (1.0%)*

 Chromosomal anomalies

426 (19.6%)

1936 (1.6%)*

Complications

 

 Respiratory failure

267 (12.3%)

6447 (5.2%)*

 Acute kidney injury

60 (2.8%)

1474 (1.2%)*

 Invasive mechanical ventilation (IMV)

262 (12.0%)

5529 (4.5%)*

 Non-invasive mechanical ventilation (NIMV)

67 (3.1%)

1877 (1.5%)*

 Myocarditis

< 11 (NA)a

193 (0.2%)

 Tachyarrhythmias

54 (2.5%)

460 (0.4%)*

 Heart block/conduction disorders

75 (3.4%)

238 (0.2%)*

 Sudden cardiac arrest

18 (0.8%)

232 (0.2%)*

 ECMOa

12 (0.6%)

199 (0.2%)*

 In-hospital mortality

44 (2.0%)

643 (0.5%)*

  1. aExtracorporeal membrane oxygenation
  2. CHD: Congenital heart disease
  3. *P-value is < 0.001 for these comparisons
  4. aHealthcare Cost and Utilization Project (HCUP) restricts subjects < 11 to be reported